ZA200806112B - Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention - Google Patents

Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention

Info

Publication number
ZA200806112B
ZA200806112B ZA200806112A ZA200806112A ZA200806112B ZA 200806112 B ZA200806112 B ZA 200806112B ZA 200806112 A ZA200806112 A ZA 200806112A ZA 200806112 A ZA200806112 A ZA 200806112A ZA 200806112 B ZA200806112 B ZA 200806112B
Authority
ZA
South Africa
Prior art keywords
egf
growth factor
composition containing
epidermal growth
topical composition
Prior art date
Application number
ZA200806112A
Other languages
English (en)
Inventor
Pupo Escalona Elder
Berlanga Acosta Joge Amador
Betancourt Rodriguez Blas Yamir
Paez Meireles Rolando
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of ZA200806112B publication Critical patent/ZA200806112B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200806112A 2005-12-29 2008-07-14 Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention ZA200806112B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20050282A CU23411B6 (es) 2005-12-29 2005-12-29 Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético

Publications (1)

Publication Number Publication Date
ZA200806112B true ZA200806112B (en) 2009-10-28

Family

ID=37831654

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806112A ZA200806112B (en) 2005-12-29 2008-07-14 Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention

Country Status (15)

Country Link
US (1) US20090074850A1 (xx)
EP (1) EP1970071B1 (xx)
JP (2) JP5715326B2 (xx)
KR (1) KR20080083033A (xx)
CN (2) CN101374541A (xx)
AR (1) AR058590A1 (xx)
AU (1) AU2006331223B2 (xx)
BR (1) BRPI0620733A2 (xx)
CA (1) CA2635013C (xx)
CU (1) CU23411B6 (xx)
MY (1) MY184122A (xx)
PL (1) PL1970071T3 (xx)
RU (1) RU2394590C2 (xx)
WO (1) WO2007073704A1 (xx)
ZA (1) ZA200806112B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23388B6 (es) * 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
US20110308985A1 (en) * 2009-02-26 2011-12-22 Gina Van Bogaert Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
CN102247300A (zh) * 2010-12-24 2011-11-23 天津天狮生物发展有限公司 人表皮生长因子纳米脂质体及其制备方法
CN102302416B (zh) * 2011-08-26 2012-12-05 广东丸美生物技术股份有限公司 一种辅酶q-10/egf脂质体、制备方法和应用
CN102949345A (zh) * 2012-06-15 2013-03-06 深圳职业技术学院 重组人表皮生长因子阳离子脂质体及其制备方法
CU24121B1 (es) 2012-08-02 2015-08-27 Ct De Ingeniería Genética Y Biotecnología Vesículas que comprenden factor de crecimiento epidérmico y composiciones que las contienen
US11628227B2 (en) * 2017-07-05 2023-04-18 Wisconsin Alumni Research Foundation Mineral coated microparticles for gene delivery in chronic wound therapy
KR101973960B1 (ko) 2017-09-29 2019-04-30 티앤에이치바이오(주) 글루타티온이 함유된 캡슐형 표피 성장 인자의 조성물 및 이로 제조되는 글루타티온이 함유된 캡슐형 표피 성장 인자
KR101964156B1 (ko) 2017-12-27 2019-08-07 티앤에이치바이오(주) 표피 성장 인자(egf) 기능 활성화 및 구조 안정화 조성물
CN118121545A (zh) * 2018-11-19 2024-06-04 奥维嘉生物科技（北京）有限公司 一种制备柔性脂质体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3990445A (en) * 1975-01-03 1976-11-09 Valleylab, Inc. Drug injection device
DE3837450A1 (de) * 1988-11-04 1990-05-10 Huels Chemische Werke Ag Verfahren zur herstellung von 1.1-diphenylethan mit guter geruchsqualitaet
US4944948A (en) 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
JPH04505319A (ja) * 1989-04-04 1992-09-17 アルコン　ラボラトリーズ　インコーポレイテッド 創傷、切傷および擦傷に対する治療剤のデリバリーとしてのリポソームの使用
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
EP0437577A1 (en) * 1989-08-01 1991-07-24 The University Of Michigan Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
US6635674B1 (en) * 1998-11-06 2003-10-21 Bristol-Myers Squibb Co. Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
HK1077740A1 (en) * 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
BR0303362A (pt) * 2002-03-06 2005-07-19 Univ Arizona State Composição e método para melhorar uma resposta imune em um animal, método para distribuir uma proteìna de carga em uma célula de animal, célula viva geneticamente modificada, e, método para a construção de uma proteìna de fusão para melhorar a resposta imune em um animal
EP1482966B1 (en) * 2002-03-12 2014-05-14 Bio-Click Technologies Ltd Method and composition for treating skin wounds with epidermal growth factor
GB0422439D0 (en) * 2004-10-08 2004-11-10 European Molecular Biology Lab Embl Inhibitors of infection
CU23388B6 (es) * 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
RU2008131070A (ru) 2010-02-10
AR058590A1 (es) 2008-02-13
JP2009522213A (ja) 2009-06-11
CU23411B6 (es) 2009-09-08
JP2013107912A (ja) 2013-06-06
AU2006331223A1 (en) 2007-07-05
US20090074850A1 (en) 2009-03-19
CN101374541A (zh) 2009-02-25
AU2006331223A8 (en) 2008-09-11
WO2007073704A1 (es) 2007-07-05
CA2635013C (en) 2015-09-29
PL1970071T3 (pl) 2015-05-29
MY184122A (en) 2021-03-19
EP1970071A1 (en) 2008-09-17
JP5715326B2 (ja) 2015-05-07
CA2635013A1 (en) 2007-07-05
AU2006331223B2 (en) 2011-12-22
KR20080083033A (ko) 2008-09-12
RU2394590C2 (ru) 2010-07-20
EP1970071B1 (en) 2014-12-17
BRPI0620733A2 (pt) 2011-11-22
CN104623632A (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
ZA200806112B (en) Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
IL189230A0 (en) Surgical tourniquet cuff for limiting usage to improve safety
SG114707A1 (en) Breathable sole structure for footwear
HK1149195A1 (en) Insulin formulations for insulin release as a function of tissue glucose levels
EP1933858A4 (en) MEDICAL COMPOSITION FOR TREATING INJURIES
PL1776090T3 (pl) Stabilizowana kompozycja prostaglandyny
IL194968A0 (en) Formulations containing pyridazine compounds for treating neuroinflammatory diseases
ZA200710139B (en) Epidermal growth factor composition, a process therefor and its application
GB0427444D0 (en) Improvements relating to skin dressings
ATE437631T1 (de) Pharmazeutische zusammensetzung von mikrokügelchen zur verhinderung einer amputation eines diabetischen fusses
ZA200906303B (en) COMPOSITIONS COMPRISING(s)-2-2AMINO-1-1(4-CHLOROPHENYL)-1-1[4-(1H-PYRAZOL-4-YL)-PHHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES
HK1121070A1 (en) Novel composition for tumor growth control
ATE422897T1 (de) Verwendung einer epidermalen wachstumsfaktor (egf) enthaltenden pharmazeutischen zusammensetzung zur vermeidung einer fussamputation bei diabetes
ZA200902311B (en) Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
TWI370741B (en) Stable liquid compositions for treating stomatitis comprising epidermal growth factor
PL1856146T3 (pl) Analogi czynnika wzrostu fgf
EP1976375A4 (en) STORAGE-STABLE CELL COMPOSITION FOR FULL BLOOD WITH INCREASED D-DIMER QUANTITIES
EP1858841A4 (en) STERILIZING COMPOSITION CONTAINING W-ALKOXYPEROXY CARBOXYLIC ACID
IL187114A0 (en) Diagnostic marker for diabetic vascular complications
HK1172567A1 (en) Topical formulation for diabetic foot ulcers
PT1970071E (pt) Uso de uma composição tópica com factor de crescimento epidérmico (egf) para a prevenção da amputação do pé diabético
HK1119569A1 (en) Lipidated tissue factor for use as topical antihemorrhagic agent
ZA200800177B (en) A composition for wound healing and use thereof
WO2009122351A3 (en) Anti-parkinsonian compounds mppe
WO2006117516A3 (en) Topical compositions